Further performing studies with a large patient cohort focusing on risk factors of stroke are however, necessary to examine additional biomarkers including VEGF and MCP-1 with reduced sample time after stroke onset to corroborate this preliminary data. This evidence concerns the gene VEGFA and stroke disorder.